NCT03502213View on ClinicalTrials.gov

Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance

CompletedOBSERVATIONAL
Enrollment

489

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Prostate Cancer
Sponsors
All Listed Sponsors
lead

Genomic Health®, Inc.

INDUSTRY

NCT03502213 - Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance | Biotech Hunter | Biotech Hunter